The study is being done with people who are taking their first anti-HIV drug regimen (including an Non-Nucleoside Reverse...
REPRIEVE (A5332) is a large double-blind, randomized, placebo-controlled study of pitavastatin or placebo for about 72 months....
Objectives: Primary: To develop a highly predictive algorithm that identifies TB patients who will be cured by treatment...
P1073 is a case controlled prospective, clinical, observational and pathogenesis study of HIV-infected infants and children...
Study of MDR TB Cases and Their Household Contacts: Operational Feasibility to Inform PHOENIx Trial Design
